This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Arvinas Operations, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sheryl Maxine Gough: Innovator in Breast Cancer Treatment
Introduction
Sheryl Maxine Gough is a notable inventor based in Stratford, CT, who has made significant contributions to the field of cancer treatment. She is particularly recognized for her innovative approach to treating breast cancer through the use of tetrahydronaphthalene derivatives.
Latest Patents
Gough holds a patent for "Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders." This patent addresses the treatment and prevention of breast cancer, including locally advanced or metastatic, ER+, HER2− breast cancer. The application involves administering a compound of Formula (I), or its various acceptable forms, to subjects in need of treatment.
Career Highlights
Sheryl Gough is associated with Arvinas Operations, Inc., where she continues to advance her research and development efforts in cancer therapies. Her work is pivotal in the ongoing fight against breast cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Gough collaborates with esteemed colleagues, including Andrew Philip Crew and John Flanagan, who contribute to her research initiatives and support her innovative projects.
Conclusion
Sheryl Maxine Gough's contributions to breast cancer treatment through her patented methods highlight her role as a leading inventor in the medical field. Her work not only reflects her expertise but also her commitment to enhancing the lives of those affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile